Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA issues nonapprovable letter for IntraDose

Nov. 9, 2001

TAP prodrug of duocarmycin derivative shows increased tumor specificity

Nov. 9, 2001

Antitumor activity of new VEGFR2 inhibitor under study at Boehringer Ingelheim

Nov. 9, 2001

Inhibitors of MEK potentially useful for proliferative disorders described in patent

Nov. 8, 2001

Novel cancer-related protein identified by Georgetown and NeoPharm

Nov. 8, 2001

Clinical evaluation of novel anticancer agent CT-2584 summarized at recent meeting

Nov. 8, 2001

Optimal dose and schedule of administration determined for Apomine

Nov. 8, 2001

Orally active taxane profiled at recent international cancer conference

Nov. 8, 2001

Oral pan-erbB tyrosine kinase inhibitor shows evidence of activity, good tolerance in phase I

Nov. 8, 2001

Enrollment commences in phase I/II Neoquin trial for early-stage bladder cancer

Nov. 8, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...